Parkinson disease drug screening based on the interaction between D2 dopamine receptor and beta-arrestin 2 detected by capillary zone electrophoresis
{{custom_author.name}}, {{article.zuoZheEn}}
Parkinson disease drug screening based on the interaction between D2 dopamine receptor and beta-arrestin 2 detected by capillary zone electrophoresis
[{{custom_ref.label}}] |
{{custom_citation.content}}
|
/
〈 | 〉 |